Bobin Y. Chen
No. 12 Wulumuqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Exosomal ANGPTL2 in cerebrospinal fluid as a novel prognostic biomarker for primary central nervous system lymphoma.
Journal: Frontiers in immunology
Published: September 05, 2025
Clinical characteristics and prognosis of primary central nervous system lymphoma in China: a single-center retrospective analysis of 325 patients.
Journal: Leukemia & lymphoma
Published: August 08, 2025
Machine Learning-Enhanced Cerebrospinal Fluid N-Glycome for the Diagnosis and Prognosis of Primary Central Nervous System Lymphoma.
Journal: Journal of proteome research
Published: April 22, 2025
Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in Shanghai.
Journal: Bone marrow transplantation
Published: October 12, 2024
A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study.
Journal: Journal of inflammation research
Published: October 06, 2024
Metabolic pathway alterations in cerebrospinal fluid as diagnostic biomarkers for primary central nervous system lymphoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: August 14, 2024
Logistic regression modeling of cytokines for cerebrospinal fluid evaluation in primary central nervous system lymphoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 13, 2024
Targeted multiplex validation of CSF proteomic biomarkers: implications for differentiation of PCNSL from tumor-free controls and other brain tumors.
Journal: Frontiers in immunology
Published: November 23, 2023
Enhanced clinical outcomes with radiotherapy in diagnostically challenging intracranial plasmacytomas: Analysis of 190 cases.
Journal: Cancer medicine
Published: September 26, 2023
Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 07, 2023
Last Updated: 09/26/2026